前立腺がん治療の世界市場見通し2017-2023

◆英語タイトル:Prostate Cancer Therapeutics - Global Market Outlook (2017-2023)
◆商品コード:SMRC70728049
◆発行会社(調査会社):Stratistics MRC
◆発行日:2017年6月
◆ページ数:148
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥456,500見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥577,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、前立腺がん治療の世界市場について調査・分析し、前立腺がん治療の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
- エグゼクティブサマリー
- 序文
- 前立腺がん治療の世界市場:市場動向分析
- 前立腺がん治療の世界市場:競争要因分析
- 前立腺がん治療の世界市場:投薬クラス別
抗がん剤治療
標的治療
ホルモン治療
免疫治療

- 前立腺がん治療の世界市場:配送経路
病院薬局
小売薬局
オンライン販売
その他の配送経路
- 前立腺がん治療の世界市場:主要地域別分析
- 前立腺がん治療の北米市場規模(アメリカ市場等)
- 前立腺がん治療のヨーロッパ市場規模
- 前立腺がん治療のアジア市場規模(日本市場、中国市場、インド市場等)
・前立腺がん治療の世界市場:主な市場開拓
- 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Prostate Cancer Therapeutics market is estimated at $XX million in 2016 and is expected to reach $XX million by 2023 growing at a CAGR of XX% from 2016 to 2023. Increase in prostate cancer cases in recent years and raise in development of innovative drugs are the some of the prominent factors driving the market growth. Whereas high cost and low success rate in the clinical test are hampering the market. However, increase in geriatric population and increase in R&D expenditure in this market seems to be opportunity for the market growth. In 2016, North America accounted for the highest market share owing to increase in research and development expenditure. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of government initiatives on creating awareness on prostate cancer.

Some of the key players in the market include Tolmar Inc, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, Ipsen, Ferring Pharmaceuticals, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc), Dendreon Corporation, Bristol-Myers Squibb, Astrazeneca Plc, Astellas Pharma Inc, Active Biotech and Abbott Laboratories.

Drugs Classes Covered:
• Chemotherapy
o Estramustine (Emcyt)
o Mitoxantrone (Novantrone)
o Jevtana
o Taxotere
• Targeted Therapy
o Xofigo
• Hormonal Therapy
o Anti-Androgens
o Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
o Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
• Immunotherapy
o Provenge

Distribution Channels Covered:
• Hospital Pharmacy
• Retail Pharmacy
• Online Sales
• Other Distribution Channels

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Prostate Cancer Therapeutics Market, By Drugs Class
5.1 Introduction
5.2 Chemotherapy
5.2.1 Estramustine (Emcyt)
5.2.2 Mitoxantrone (Novantrone)
5.2.3 Jevtana
5.2.4 Taxotere
5.3 Targeted Therapy
5.3.1 Xofigo
5.4 Hormonal Therapy
5.4.1 Anti-Androgens
5.4.1.1 Casodex
5.4.1.2 Xtandi
5.4.2 Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
5.4.2.1 Zytiga
5.4.2.2 Gonax
5.4.2.3 Firmagon
5.4.3 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
5.4.3.1 Vantas
5.4.3.2 Eligard
5.4.3.3 Decapeptyl
5.4.3.4 Zoladex
5.4.3.5 Lupron
5.5 Immunotherapy
5.5.1 Provenge

6 Global Prostate Cancer Therapeutics Market, By Distribution Channel
6.1 Introduction
6.2 Hospital Pharmacy
6.3 Retail Pharmacy
6.4 Online Sales
6.5 Other Distribution Channels

7 Global Prostate Cancer Therapeutics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Tolmar Inc
9.2 Teva Pharmaceutical Industries Ltd
9.3 Takeda Pharmaceutical Co. Ltd
9.4 Sanofi-Aventis
9.5 Pfizer Inc
9.6 Johnson & Johnson
9.7 Ipsen
9.8 Ferring Pharmaceuticals
9.9 Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc)
9.10 Dendreon Corporation
9.11 Bristol-Myers Squibb
9.12 Astrazeneca Plc
9.13 Astellas Pharma Inc
9.14 Active Biotech
9.15 Abbott Laboratories

List of Tables
Table 1 Global Prostate Cancer Therapeutics Market Outlook, By Region (2015-2023) ($MN)
Table 2 Global Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)
Table 3 Global Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)
Table 4 Global Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)
Table 5 Global Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)
Table 6 Global Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)
Table 7 Global Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)
Table 8 Global Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)
Table 9 Global Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)
Table 10 Global Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)
Table 11 Global Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)
Table 12 Global Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)
Table 13 Global Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)
Table 14 Global Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)
Table 15 Global Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)
Table 16 Global Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)
Table 17 Global Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)
Table 18 Global Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)
Table 19 Global Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)
Table 20 Global Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)
Table 21 North America Prostate Cancer Therapeutics Market Outlook, By Country (2015-2023) ($MN)
Table 22 North America Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)
Table 23 North America Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)
Table 24 North America Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)
Table 25 North America Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)
Table 26 North America Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)
Table 27 North America Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)
Table 28 North America Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)
Table 29 North America Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)
Table 30 North America Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)
Table 31 North America Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)
Table 32 North America Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)
Table 33 North America Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)
Table 34 North America Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)
Table 35 North America Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)
Table 36 North America Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)
Table 37 North America Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)
Table 38 North America Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)
Table 39 North America Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)
Table 40 North America Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)
Table 41 Europe Prostate Cancer Therapeutics Market Outlook, By Country (2015-2023) ($MN)
Table 42 Europe Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)
Table 43 Europe Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)
Table 44 Europe Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)
Table 45 Europe Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)
Table 46 Europe Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)
Table 47 Europe Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)
Table 48 Europe Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)
Table 49 Europe Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)
Table 50 Europe Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)
Table 51 Europe Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)
Table 52 Europe Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)
Table 53 Europe Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)
Table 54 Europe Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)
Table 55 Europe Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)
Table 56 Europe Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)
Table 57 Europe Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)
Table 58 Europe Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)
Table 59 Europe Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)
Table 60 Europe Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)
Table 61 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Country (2015-2023) ($MN)
Table 62 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)
Table 63 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)
Table 64 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)
Table 65 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)
Table 66 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)
Table 67 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)
Table 68 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)
Table 69 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)
Table 70 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)
Table 71 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)
Table 72 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)
Table 73 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)
Table 74 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)
Table 75 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)
Table 76 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)
Table 77 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)
Table 78 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)
Table 79 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)
Table 80 Asia Pacific Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)
Table 81 RoW Prostate Cancer Therapeutics Market Outlook, By Country (2015-2023) ($MN)
Table 82 RoW Prostate Cancer Therapeutics Market Outlook, By Drugs Class (2015-2023) ($MN)
Table 83 RoW Prostate Cancer Therapeutics Market Outlook, By Chemotherapy (2015-2023) ($MN)
Table 84 RoW Prostate Cancer Therapeutics Market Outlook, By Estramustine (Emcyt) (2015-2023) ($MN)
Table 85 RoW Prostate Cancer Therapeutics Market Outlook, By Mitoxantrone (Novantrone) (2015-2023) ($MN)
Table 86 RoW Prostate Cancer Therapeutics Market Outlook, By Jevtana (2015-2023) ($MN)
Table 87 RoW Prostate Cancer Therapeutics Market Outlook, By Taxotere (2015-2023) ($MN)
Table 88 RoW Prostate Cancer Therapeutics Market Outlook, By Targeted Therapy (2015-2023) ($MN)
Table 89 RoW Prostate Cancer Therapeutics Market Outlook, By Xofigo (2015-2023) ($MN)
Table 90 RoW Prostate Cancer Therapeutics Market Outlook, By Hormonal Therapy (2015-2023) ($MN)
Table 91 RoW Prostate Cancer Therapeutics Market Outlook, By Anti-Androgens (2015-2023) ($MN)
Table 92 RoW Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists (2015-2023) ($MN)
Table 93 RoW Prostate Cancer Therapeutics Market Outlook, By Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (2015-2023) ($MN)
Table 94 RoW Prostate Cancer Therapeutics Market Outlook, By Immunotherapy (2015-2023) ($MN)
Table 95 RoW Prostate Cancer Therapeutics Market Outlook, By Provenge (2015-2023) ($MN)
Table 96 RoW Prostate Cancer Therapeutics Market Outlook, By Distribution Channel (2015-2023) ($MN)
Table 97 RoW Prostate Cancer Therapeutics Market Outlook, By Hospital Pharmacy (2015-2023) ($MN)
Table 98 RoW Prostate Cancer Therapeutics Market Outlook, By Retail Pharmacy (2015-2023) ($MN)
Table 99 RoW Prostate Cancer Therapeutics Market Outlook, By Online Sales (2015-2023) ($MN)
Table 100 RoW Prostate Cancer Therapeutics Market Outlook, By Other Distribution Channels (2015-2023) ($MN)



★調査レポート[前立腺がん治療の世界市場見通し2017-2023]販売に関する免責事項
★調査レポート[前立腺がん治療の世界市場見通し2017-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆